Dear Spiral user, We’re pleased to introduce Helix, https://helix.imperial.ac.uk/ Imperial’s new repository for research datasets. Please use Helix for all future dataset deposits. There is no change to Spiral - continue depositing as usual. For queries, contact the Research Data Management team at rdm-enquiries@imperial.ac.uk. Kind regards, the Spiral Team. The Spiral team
Evaluating the role of faecal calprotectin in older adults
File(s)
e100.full.pdf (255.49 KB)
Published version
Author(s)
Perry, Robert William
Foulser, Peter
Zhang, David
Martinez Perez, Pablo
Taylor, Shakira
Type
Journal Article
Abstract
Background Faecal calprotectin (FC) is a marker of gastrointestinal (GI) inflammation widely used in primary care to identify patients requiring referral for endoscopic assessment. Most guidelines advise against its use in older adults due to higher rates of colorectal cancer. Many studies include only younger adults, despite FC continuing to be used in older adults. Aim This study aimed to evaluate FC performance in identifying IBD and significant organic pathology in adults over 50 years, to help inform its use and interpretation in primary care. Where available, FIT was also analysed. Methods Patients who had FC testing performed followed by a colonoscopy were recruited and grouped into younger adults (aged 18-49 years), and older adults (aged ≥50 years). Results: 669 patients were included; 423 aged 18-49 years and 246 ≥50 years. There were no significant differences in FC levels between the groups (median FC 71g/g vs 85.5g/g, p = 0.29). FC >50g/g showed a high sensitivity for IBD in both groups (94.1% and 93.8%) although a low PPV, particularly in ≥50 years (12.8% vs 20.9%). FC >50g/g outperformed FIT (threshold 10g/g) for the diagnosis of IBD and organic pathology in both groups. However, in the over 50s, FIT outperformed FC at 150g/g for diagnosis of organic pathology including colorectal cancer. Conclusion: These data show that FC remains a sensitive test in older adults. FC may have a role as a “rule out” test in older adults with lower GI symptoms and a negative FIT, where colorectal cancer is not suspected.
Date Issued
2026-02-01
Date Acceptance
2025-07-15
Citation
British Journal of General Practice, 2026, 76 (763), pp.e100-e107
URI
URL
DOI
ISSN
0960-1643
Publisher
Royal College of General Practitioners
Start Page
e100
End Page
e107
Journal / Book Title
British Journal of General Practice
Volume
76
Issue
763
Copyright Statement
Copyright © 2025, The Authors This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/40774794
PII: BJGP.2025.0169
Subjects
faecal calprotectin
faecal immunochemical test
gastroenterology
inflammatory bowel diseases
primary care HRT Williams (ORCID: 0000-0001-5889-7584), gastroenterology consultant, PhD, MRCP, D Zhang, MRCP, gastroenterology registrar
A Sharma (ORCID: 0000-0001-8180-6388), MBBCh, internal medicine trainee, Northwick Park Hospital,
Publication Status
Published
Coverage Spatial
England
Article Number
BJGP.2025.0169.
Date Publish Online
2025-08-07